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Background: Atypical bovine spongiform encephalopathies (BSEs), classified as H-type and L-type BSE based on the
Western immunoblot profiles, are naturally occurring diseases in cattle, which are phenotypically different to classical
BSE. Transmission studies in cattle using the intracerebral route resulted in disease where the phenotypes were
maintained irrespective of BSE type but clinically affected cattle with a shorter survival time displayed a nervous
form whereas cattle with a longer survival time displayed a dull form. A second transmission study is reported
here where four cattle were intracerebrally inoculated with brain tissue from experimentally infected cattle presenting
with either the nervous or dull form of H- or L-type BSE to determine whether the phenotype is maintained.
Results: The four inoculated cattle were culled at 16.5-19.5 months post inoculation after presenting with difficulty
getting up, a positive scratch response (all) and dullness (three cattle), which was not observed in two non-inoculated
control cattle, each housed with either group of inoculated cattle. Only the inoculated cattle had detectable prion
protein in the brain based on immunohistochemical examination, and the Western immunoblot profile was consistent
with the H-type or L-type BSE of the respective donor cattle.
Conclusions: Second passage of H-type and L-type BSE in cattle produced a TSE where the majority of cattle displayed
the dull form regardless of clinical disease form of the donor cattle. The pathological and molecular phenotypes
of H- and L-type BSE were maintained.Background
Atypical bovine spongiform encephalopathy (BSE) is a
prion disease of usually older cattle that is distinct from
classical BSE by its pathological, molecular and bio-
logical phenotype. Two types are recognised, H-type
BSE [1] and L-type BSE (also called bovine amyloidotic
spongiform encephalopathy (BASE) [2]), which can be
differentiated based on distribution and type of disease-
associated prion protein (PrPd) in the brain [2-5] as well
as proteinase K (PK) digestion characteristics and migra-
tion pattern of the proteinase-resistant fragment of the
prion protein (PrPres) on a Western immunoblot [6,7].* Correspondence: timm.konold@ahvla.gsi.gov.uk
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article, unless otherwise stated.Atypical BSE occurs world-wide, even in those countries
with a low risk of classical BSE, with a frequency of ap-
proximately 1–2 per million cattle over 8 years old,
which led to the hypothesis that these types represent
sporadic transmissible spongiform encephalopathies
(TSEs) [8]. Furthermore, it has been suggested that atyp-
ical BSE may be the origin of the classical BSE epidemic
[9], which is supported by studies in mice that showed
that a disease phenotype indistinguishable from classical
BSE can be induced [10-13].
However, this has not yet been reproduced in the actual
host: the atypical BSE disease phenotype is maintained ac-
cording to several transmission studies of naturally occur-
ring atypical BSE to cattle by the intracerebral route
[4,14-17], and this also applies to second passages inntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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to date [18].
Clinically, the experimental disease in cattle is charac-
terised by locomotor changes and changes in behaviour
and mental status described as either increased nervous-
ness and anxiety or dullness, regardless of atypical BSE
type. Affected cattle eventually have difficulty rising, which
may explain why naturally occurring atypical BSE cases
detected through active surveillance of fallen stock often
have a history of dysstasia or recumbency [3,19-22].
We previously reported a transmission study of atypical
BSE in cattle to generate tissue for reference and European
quality assurance, which produced pathological and
molecular phenotypes consistent with the original
source (H-type and L-type BSE) but it produced two
clinical phenotypes: a nervous form, and a dull form
only seen in cattle with the longest survival time [4].
This report describes the findings in a subsequent tis-
sue generation study, which provided the opportunity
to determine whether the clinical, pathological and mo-
lecular phenotypes are maintained upon subpassage in
cattle by inoculating cattle with brains from experimental
H-type and L-type BSE-affected cattle displaying either
the nervous form or dull form.
Methods
All procedures involving animals were approved by the
Home Office of the UK government according to the
Animal (Scientific Procedures) Act 1986 under project
licence 70/7312.
Inocula
Brain homogenates (cerebral cortex in 10% w/v solution
in sterile saline) were prepared from four cattle intrace-
rebrally inoculated with H-type BSE (N = 2) and L-type
BSE (N = 2) brain in a study reported previously [4]. The
donor cattle were selected on the basis of their clinical
presentation and survival time (nervous form – shorter
survival time, dull form – longer survival time) as follows:
H-type BSE: steer H1 (nervous form, survival time
17 months) and steer H4 (dull form, survival time
21.5 months).
L-type BSE: steer L1 (nervous form, survival time
17.5 months) and steer L4 (dull form, survival time
23 months); for detailed information on donor cattle see
previous report [4].
All inocula were tested for bacterial contamination
and treated with antibiotics if required (H4 and L1 brain
homogenate) according to established methods [23].
Animals
Four Hereford crossbred calves sourced from the UK
were intracerebrally inoculated at 7 months of age with
1.0 ml of either L-type or H-type BSE brain homogenateaccording to previous published methods ([23]): steer
H5 and heifer H6 with inoculum from donors H1 and
H4 respectively, and steer L5 and heifer L6 with inocu-
lum from donors L1 and L4 respectively. EDTA blood
was collected from each animal for DNA extraction to
determine the PrP gene open reading frame (ORF) poly-
morphisms and promoter region as described previously
[24]. Both groups each included a third, age-matched
calf as an environmental control, which was not inocu-
lated: Aberdeen Angus crossbred heifer CO3 for the
H-type BSE inoculated cattle and Holstein Friesian
steer CO4 for the L-type BSE inoculated cattle.
Selection of cattle groups was purely based on avail-
ability at the start of the study, given that there has been
no evidence that the pathological or molecular phenotype
varies between breeds or gender (Hereford crossbred
steers or heifers as recipients versus Aberdeen Angus
crossbred steers as donors), but it was decided to use the
same breed for the inoculated cattle to enable comparison
between phenotypes.
Husbandry and routine procedures
Both groups were housed in medium security accommo-
dation with no contact between groups, with separate
pen entrances and separate equipment. All housed cattle
were given hay ad libitum and a daily concentrate ration
free from meat and bone meal. Routine procedures in-
cluded monthly weighing of all cattle, one pre-inoculation
and then monthly blood sampling from 1 month post in-
oculation (mpi) of inoculated cattle until 13 mpi when
routine blood sampling was discontinued to prevent stress
during sampling and enable comparison of the clinical
presentation with the control cattle, which were not
sampled.
Clinical assessments
All animals were clinically examined prior to inoculation
to confirm their suitability for the study.
Behavioural observations
Animals were checked daily by animal husbandry staff
and any unusual behaviour during feeding or cleaning of
the pens was recorded. Scientific or veterinary staff car-
ried out weekly observations for 15 minutes per pen be-
tween 10:30 a.m. and 12 noon to assess the animals’
behaviour and mental status and reactivity [23]. These
observations, which started from 9 mpi were conducted
without interaction of the observer except for the ‘hand
approach test’ (moving the hand towards the animal
when close to the observer at the door) or the clipboard
test (waving a clipboard towards the animal) at the end
of the observation period if an animal did not approach.
Similar to the previous study, animals were also moni-
tored during daytime by closed circuit television using
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version 3, AXIS Communications, Lund, Sweden) mounted
in opposite corners of each pen. Weekly camera observa-
tions were conducted from 10.5 mpi to assess the cattle’s
rising behaviour and general activity. Rising behaviour was
later also specifically assessed by animal husbandry staff
when the first difficulty in getting up was noticed.
The scoring system for rising behaviour was similar to
that used in the previous study:
score 0 = getting up without delay, rising on hind
limbs first;
score 1 = slight difficulties getting up, e.g. the phase of
rising on the hind limbs seems to be delayed;
score 2 = obvious difficulties getting up with rising on
the fore limbs first or dragging the body along the floor
before getting up;
score 3 = unable to get up, the animal may attempt to
do so but does not succeed; this score was also given to
cattle that were unable to get up but got up when aided
by staff.
Neurological examinations
Neurological examinations were conducted at 6, 9 and
12 mpi and monthly thereafter. As in previous studies,
clinical examinations consisted of a neurological examin-
ation according to a standard protocol [23], which in-
cluded inspection of the retina and tests of over-reactivity,
such as testing the response to camera flash (‘flash test’),
to hand clapping and a metallic bang, to a clipboard
waved in front of the animal (‘clipboard test’) and to
touching of the hind limbs with a flexible stick (’stick test’)
[25]. In addition, testing of the scratch response was car-
ried out from 17 mpi whereby the back of cattle was
scratched to assess whether a repeatable, stereotypical
response could be elicited. This test had been used rou-
tinely in sheep with TSE, with nibbling movements of
the lips, lip licking (“nibble reflex”) or rhythmical head
or body movements being scored as positive [26]. All
animals were assessed by the same veterinary clinician
but due to the breed differences it was known to the
veterinary and scientific staff from the outset which an-
imals were inoculated with atypical BSE although the
BSE-type (H- or L-type) was not disclosed.
Clinical end-point
Cattle were culled by intravenous injection of pentobar-
bitone at clinical end-point when they displayed signs in
at least two of the three categories ‘changes in mental
status, behaviour and activity’, ‘changes in sensation’ and
‘changes in posture and movement’ or – based on previ-
ous experience with the clinical picture of experimental
atypical BSE in cattle where behavioural or gait changes
may be more subtle than in classical BSE [4] – had consid-
erable difficulty getting up likely to result in permanentrecumbency. Control cattle were culled when the last
inoculated animal in their pen was culled.
Postmortem diagnostic tests
Histopathology and immunohistochemistry
The brain of each inoculated animal was removed and
the right half fixed in 10% formal saline for histopatho-
logical and immunohistochemical examination, and the
left half was frozen at −80°C. Sections representing stan-
dardised levels of the fixed brain [27,28] were prepared
from paraffin wax-embedded blocks using routine histo-
logical methods and stained with haematoxylin and
eosin (H&E) for the detection of vacuolar changes as de-
scribed previously [27]. Further sections were immuno-
labelled with the rat anti-PrP monoclonal antibody
(mAb) R145 (Animal Health and Veterinary Laboratories
Agency, Addlestone, UK) for the detection of PrPd as
described in detail elsewhere [28,29].
Immunohistochemical examination was also performed
on spinal cord sampled at four levels (C6–7, T4–5, T9–10
and L2–3), mesenteric lymph node, distal ileum, palatine
tonsil, medial retropharyngeal lymph node, trigeminal
ganglion and extraocular muscles, together with samples
from the triceps, medial gluteal and semitendinosus mus-
cles from all animals except L6, from which only limited
samples could be taken.
Only the brainstem was sampled from control cattle for
histopathological and immunohistochemical examination.
Western immunoblotting
Fresh, frozen samples of brainstem from inoculated cattle
were processed using the BioRad TeSeE universal Western
blot (WB) kit (BioRad Laboratories, Marnes-La-Coquette,
France) according to the manufacturer’s instructions as de-
scribed previously [4]. The mAbs used to detect the
proteinase-resistant fraction of the prion protein (PrPres)
were SHA31 (BioRad Laboratories, included in the WB
kit), P4 (R-BioPharm, Darmstadt, Germany) and SAF84
(Cayman Chemicals, Ann Arbor, USA). Where necessary,
sample dilutions were carried out in Laemmli sample buffer
(BioRad Laboratories) prior to loading on the gel. The
signal was visualised by chemoluminescence and the
image captured using a Fluor-S multiImager (BioRad
Laboratories).
Results
Animal data and clinical disease
Genotyping revealed that all inoculated cattle had PrP
alleles with six octapeptide repeats (6:6); the cattle inoc-
ulated with H-type BSE also had silent single nucleotide
polymorphisms at codon position N192 (AAY instead of
AAC) within the PrP gene ORF. All animals were homo-
zygous for the deletion in the 23 bp and 12 bp indels.
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logical signs suggestive of BSE. The estimated clinical
onset, characterised by the display of subtle gait changes
with difficulty getting up or behavioural abnormalities,
was between 13.5 and 16.5 mpi and the clinical duration
was 3–4 months. Control cattle were culled at 17 months
(CO3 in H-type group) and 19.5 months (CO4 in L-type
group) after test group inoculation. Figure 1 shows times of
clinical onset, clinical duration and survival time (in mpi) at
clinical end-stage for each inoculated animal and its corre-
sponding donor of the atypical BSE brains.
Selected clinical signs observed in the inoculated cattle
over time and clinical findings in control cattle for com-
parison are displayed in Figure 2.
The predominant clinical sign in all cattle was diffi-
culty getting up, characterised by rocking several times
before getting up (score 1), crawling along the floor be-
fore getting up (score 2, see additional file 1 – H5 where
the animal can be seen rocking and briefly crawling
along the floor before getting up) and inability to get up
(score 3, not seen in animal H5), even though the ani-
mals were able to rise without major difficulty when
aided. At the first detection of difficulty getting up, cattle
had usually displayed mild hind limb gait abnormalities
(hind limb ataxia and hypermetria), which became more
obvious as the disease progressed. Behavioural and sen-
sory abnormalities (apprehension in the corridor, restless
behaviour when restrained in a crush, over-reactivity toFigure 1 Time to clinical onset, duration and survival time in atypical
duration and survival times between H- and L-type BSE brain recipients L5,
and H4, which were intracerebrally inoculated with atypical BSE brain from
H5 and H6 and L type recipient L5 were similar, with only 20 days between
L6 was culled two months after animals L5 and H6. Clinical duration and surv
onset was earlier in two of the atypical BSE donors, L1 and H1, compared to texternal stimuli or unexpected startle reactions) were
seen from the first examination after inoculation but did
not progress and were also displayed in control cattle.
With the exception of L6, all other inoculated cattle (H5,
H6 and L5) became dull, which was most evident on
passive observations and CCTV observations: affected
cattle stood with their heads close to the wall or dividing
gate or occasionally rested their heads against them.
Whilst the eyes were closed, the cattle then gradually
lowered their heads towards the floor (see additional
file 1 – H5, which shows this steer gradually lowering
its head along the wall).
Unexpectedly, all inoculated cattle displayed a positive
scratch test, characterised by lip movements when the
tail head was scratched. Scratch testing was not rou-
tinely performed in cattle, and a positive response was
first noticed by coincidence in animal H5 prior to cull
when the animal was scratched on the tail head in the
pen (see additional file 1 – H5, which shows the steer
moving its lips in response to scratching the tail head).
The scratch test was subsequently done in the other in-
oculated cattle, which responded similarly, whereas no
response was elicited when the tail head of the control
cattle was scratched. Over the course of two weeks, the
regions that elicited a positive scratch response extended
further rostral in animal L6, which had the longest sur-
vival time (see additional file 2 – L6, which shows the
progression in the response to the scratch test). None ofBSE brain donors and recipients. Comparison of clinical onset,
L6, H5 and H6 and the respective H- and L-type BSE donors L1, L4, H1
naturally occurring cases. The survival times of both H-type recipients
the first (H5) and the last (L5 and H6) culled animals, whereas animal
ival times were longer in the atypical BSE brain donors, whereas clinical
he recipients L5 and H5 respectively.
Figure 2 Clinical findings in L- and H-type BSE cases over time compared with controls. Difficulty getting up and gait abnormalities were
seen in all four cases, dullness in three cases. Clinical findings were derived from observations and examinations. The horizontal axis represents
the time points when neurological examinations were done; a symbol at a particular time point indicates that the sign was observed between
this and the previous time point. The vertical, dotted orange lines indicate estimated clinical onset, the vertical, grey interrupted lines the time of
cull. Head shy/restless in crush: e.g. head tossing or backing off when faced in crush. Over-reactive to tactile stimuli: e.g. head tossing in response
to touching of the head. Abnormal tests of over-reactivity: startle at flash, clipboard test or hand clap, kicking on stick test. Abnormal gait:
e.g. dysmetria.
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area that elicited a scratch response.
Postmortem test findings
Histopathological and immunohistochemical examination
None of the control cattle had detectable vacuolar
changes or PrPd immunolabelling in the obex.
All four challenged animals displayed vacuolar lesions
and immunopathology, which was completely consistent
with the morphology and neuroanatomical distribution
of immunolabelling previously described in the donor
animals [4]. Briefly, extensive particulate and small aggre-
gate immunolabelling was present throughout the neur-
axis of all four animals, with glial labelling a predominant
additional feature in H5 and H6 and perineuronal label-
ling in L5 and L6. Both patterns of immunolabelling were
distinct from each other, and different from classical BSE.
As before, there was no observed involvement of the
lymphoreticular system in any animal, and peripheral
immunolabelling was confined to muscle spindles. There
was no evidence of amyotrophic lesions in examined
sections of the gluteal and triceps muscles.Western immunoblot examination
The WB profile displayed by each of the four recipi-
ents conformed to the recognised characteristics of H
or L-type BSE when detected with each of the three
mAbs. Furthermore there was no apparent difference
in the profiles between the nervous and dull clinical
types (see Figure 3).
Essentially, H-type BSE displayed a high molecular
mass migration with mAb SHA31, detection at a similar
intensity with mAb P4 and a reduced volume of PrPres
in the diglycosylated band and additional low molecular
mass band at approximately 14 kD with mAb SAF84.
L-type BSE displayed a low molecular mass migration
with both mAbs SHA31 and SAF 84, similar ratio of
PrPres in the di- and monoglycosylated bands with mAb
SHA31 and was not detected with mAb P4.
Discussion
H-type and L-type BSE are prion diseases of cattle with
distinct differences in the pathological and molecular
phenotype, which are maintained after experimental
transmission of naturally occurring disease to cattle
Figure 3 Western immunoblot of brainstem samples from the
four recipients detected with three different antibodies. A: mAb
SHA31, B: mAb P4 and C: mAb SAF84. Lane Key: M Molecular mass
marker. 1 & 7 Classical BSE control. 2 & 8 Classical scrapie control.
3 H5. 4 H6. 5 L5. 6 L6.
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visual WB PrPres profiles observed in the secondary pas-
sage recipient cattle maintained the same characteristics
as the respective donor and primary passage recipients
previously published [4], which confirmed that no
change in the pathological and molecular H- or L-type
profile occurred upon subpassage in the bovine host.
This had been previously described for the Japanese
BASE-like isolate BSE/JP24 [18]. Thus, the current study
did not provide any evidence that the atypical BSE char-
acteristics may change into classical BSE following sub-
passage in cattle. Transmission studies in wild-type mice
have shown that both atypical BSE types may convert
into classical BSE [10,12,30], and this was also demon-
strated in bovine transgenic mice for H-type BSE [11]. If
this phenotype change, which is seen only inconsistently
in mice, also occurs in cattle, it may not be detectable in
the few studies of atypical BSE in cattle, which generally
have only small sample sizes.
The current study showed that difficulty getting up
remained the major clinical sign in the H- and L-type
BSE-affected cattle, which is consistent with the previous
[4] and other studies conducted elsewhere [14-18].
Muscle atrophy and fasciculations as observed in experi-
mentally infected BASE-affected cattle [14] were not ob-
served. Although all affected cattle were able to get up
unaided from a sternal lying position even at clinical
end-stage, three cattle were found in a lateral position
and unable to right themselves unaided, which wouldhave ultimately resulted in death. If naturally occurring
atypical BSE has a similar clinical presentation, it is un-
likely that these cases would have been associated with
BSE under normal farming practice and reported as sus-
pects unless the recumbency had been preceded by gait
abnormalities that had been recognised by the herds-
man. This supports the field situation, in which the great
majority of atypical BSE cases have been identified
through the statutory active screening of fallen stock
and emergency slaughter populations [31]. In the ab-
sence of reported clinical suspects, detailed description
of the clinical phenotype to aid in the recognition of
clinical disease in the field can only be obtained from
experimental studies.
Signs often observed in classical BSE, such as over-
reactivity to external stimuli, unexpected startle re-
sponses, apprehension and anxiety, which were also
present in the atypical BSE-affected donor cattle and
interpreted as the ‘nervous disease form’ [4], were not a
feature in the current study, although head tossing, nose
licking and teeth grinding associated with classical BSE
[32] were seen in one animal (H5). This steer and two
other cattle became dull, including L5, whose donor had
never displayed the dull form of the disease. Surpris-
ingly, the animal with the longest survival time and lon-
gest clinical duration (L6) did not appear to be dull
(classified as displaying the nervous form in Figure 1
even though head shyness was the only sign of over-
reactivity), whereas the donor animal had displayed the
dull form. Although based on only one animal, it does
not support the hypothesis that affected animals become
duller as the disease progresses, even though lesions in
the brain become more widespread and may affect the
forebrain, diencephalon and the reticular activating system
in the brainstem, which are associated with an altered
state of alertness [33]. The lack of a clear relationship be-
tween morphological changes or PrPd accumulation and
clinical signs has been reported before in large animals af-
fected by prion diseases [34-36]. There were no obvious
differences in the neuropathology of individual cattle that
could explain the difference in the clinical presentation
and there was also no discernable molecular profile dif-
ference between the two L-type recipients (presence or
absence of dullness).
Dullness was consistently reported as a sign of H- or
L-type BSE-affected cattle in other studies [14-17]. We
cannot exclude the possibility that the display of ner-
vousness is dependent on breed, as it has been shown
for classical BSE where the occurrence of temperament
changes and kicking was less frequent in Guernsey cattle
[37]. As reported for the previous study, the prion protein
genotype did not appear to affect the clinical presentation
as both dull and non-dull forms occurred in cattle with
the same genotype, inoculated with L-type BSE.
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necessarily maintained in the recipient because the survival
times in the H-type affected cattle were similar whereas
there had been a difference of more than 4 months in the
donors. The clinical duration appeared to be much more
uniform and similar in all recipient cattle, even though the
inoculum was derived from different cattle, whereas the
duration in the donors had been more variable despite the
use of the same inoculum for H-type and L-type inoculated
cattle respectively. This is most likely due to the reliance on
certain clinical markers to define clinical onset, which were
difficulty getting up and gait abnormalities in the absence
of behavioural abnormalities that were clearly distinguish-
able from control cattle in the present study, whereas the
donor cattle displayed over-reactivity relatively early in the
incubation period, which was associated with disease, be-
cause it was not seen in the control cattle. In general, the
differences in survival time and clinical duration between
donor and recipients have to be interpreted with caution be-
cause only single animal to animal transmissions were done.
The presence of a positive scratch test in all atypical
BSE-affected cattle was unexpected. Contrary to TSE-
affected sheep where this sign is frequently observed
[26,38] although the pathological mechanism that pro-
duces pruritus is unknown, it has only been reported in
a small number of classical BSE cases [39,40] and is usu-
ally not tested in BSE-affected cattle. It is also not part
of the routine examination protocol for signs of BSE in
cattle used in this and other studies in our laboratory
and was also not tested in the donor cattle because no
response is usually elicited (T Konold, unpublished ob-
servation). A positive scratch response, however, can be
observed in cattle suffering from Chorioptes bovis infest-
ation (T Konold, unpublished observation), which often
affects the skin around the tail head resulting in crusts
and scabs (“tail mange”). We neither found skin lesions
suggestive of Chorioptes mange nor did we observe
signs of excessive pruritus on CCTV or weekly behav-
ioural observations. Grooming behaviour was similar in
atypical BSE-affected cattle and non-inoculated control
cattle that were housed in the same pen but did not dis-
play a scratch response (data not shown). A larger sample
size is required to evaluate whether this sign is specifically
present in cattle with atypical BSE or an incidental finding,
and it would be interesting to apply this test to recumbent
cattle (downer cows) where no definite clinical diagnosis
can be established and atypical BSE cannot be ruled out.
Conclusions
Second passage of H-type and L-type BSE in cattle by in-
tracerebral inoculation produced a TSE where the major-
ity displayed the dull disease form regardless of disease
form of the donor cattle. The pathological and molecular
phenotypes of H- and L-type BSE were maintained.Additional files
Additional file 1: H5. This steer shows difficulty rising on its hind limbs
at 16.5 mpi. It sniffs the gloved hand of the clinician followed by head
tossing and bobbing, nose licking and teeth grinding (‘BSE series of
events’). The menace response and the response to touching of the head
in the crush are considered normal. The steer is generally too reluctant to
walk at a faster pace to appreciate gait abnormalities but hind limb ataxia
is evident when it follows the other animal and crosses the hose on the
floor. Scratching of the tail head elicits lip movements (positive scratch
test). The steer can be seen standing in the pen and leaning its head
against the bars of the pen division or resting it against the wall, with the
eyes closed, which gradually slides down towards the floor. This episode
lasts for approximately 8 minutes as indicated by the timer at the bottom
of the clip.
Additional file 2: L6. This heifer is first seen walking along a corridor at
12.5 mpi, when its gait appears normal. It repeatedly responds to
scratching of the tail head with lip movements and nose licking when
examined 6 months later, which is not displayed by the control steer
CO4 (inset), and has also developed hind limb ataxia. There is slight loss
of balance after exiting the crush and it crosses its hind limbs occasionally
when walking. The abnormal gait, which includes hind limb hypermetria, is
more evident when the heifer trots. One day prior to cull, at 19.5 mpi, only
slight difficulty getting up was noted on CCTV (rocking once before getting
up; the heifer is indicated by a white arrow), but the heifer was found in
lateral recumbency the next morning and only able to get up after being
placed in a sternal position. When examined afterwards, there is mild
over-reactivity to menace response testing and touching of the head.
The scratch testing response is repeatable, more pronounced and can
be elicited by scratching more cranial areas of the back, which results
in head and neck movements followed by nose licking.
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